🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for HIV-1-infection

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test NCT07563309NA3 sites📍 Johannesburg📍 Durban📍 Cape Town bioLytical Laboratories · Tests: TruPlex HIV/HepB/Syphilis Rapid Test Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV NCT04174755NA1 site📍 Dublin University College Dublin · Tests: Semaglutide Injectable Product, Standard of care Substudy-01: A Study of Long-Acting HIV-1 Treatments Taken by Mouth in People With HIV-1 With Undetectable Virus Levels NCT07841990Phase 22 sites📍 Ft. Pierce📍 Houston Gilead Sciences · Tests: B/F/TAF, GS-3242, Lenacapavir Immuno-virological Evaluation of Persons Living With HIV (PLWH) NCT05973825NA1 site📍 Ghent University Hospital, Ghent · Tests: Leucapheresis Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein NCT06441123n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Blood Sampling A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) NCT07202546Phase 2123 sites📍 Bakersfield📍 Palm Springs📍 West Hollywood ViiV Healthcare · Tests: VH4524184, Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets, Dolutegravir / Lam… Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1) NCT07711223Phase 1, Phase 21 site📍 Beijing Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Tests: ACC017+FTC/TAF, DTG+FTC/TAF Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women NCT07616739Phase 410 sites📍 Ciudad Autónoma de Buenos Aires📍 Ciudad Autónoma de Buenos Aires📍 Ciudad Autónoma de Buenos Aires Fundación Huésped · Tests: Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO], TDF/XTC or TAF/FTC plus Dolutegravir (XTC stand for lamivudi… Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated. NCT04160455n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: expression of a panel Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease. NCT04098315n/a1 site📍 Milan Castagna Antonella · Tests: REGISTER CREATION Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset NCT06834113NA5 sites📍 Orléans📍 La Roche-sur-Yon📍 Le Coudray Centre Hospitalier Régional d'Orléans · Tests: Dorsogluteal intramuscular injection A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) NCT07266831Phase 2, Phase 355 sites📍 Los Angeles📍 Denver📍 Washington D.C. Merck Sharp & Dohme LLC · Tests: ISL, ULO, BIC/FTC/TAF, Placebo for BIC/FTC/TAF, Placebo to ISL/ULO REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE NCT07476339Phase 410 sites📍 Clearwater📍 Ft. Pierce📍 Jacksonville CAN Community Health · Tests: Bictegravir, emtricitabine, and tenofovir alafenamide A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 NCT07645287Phase 257 sites📍 Phoenix📍 Beverly Hills📍 Los Angeles Gilead Sciences · Tests: GS-3242 Tablet, GS-3242 Injection, Lenacapavir Tablet, Lenacapavir Injection, B/F/TAF PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) NCT03729752Phase 11 site📍 San Francisco University of California, San Francisco · Tests: [89]Zr-DFO-VRC-HIVMAB060-00-AB Improving Coronary Vascular Health in Women NCT06843902Phase 21 site📍 Boston Massachusetts General Hospital · Tests: Health Education, Subspecialty clinic referral Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals NCT06805656Phase 21 site📍 São Paulo Federal University of São Paulo · Tests: Maraviroc, Dolutegravir, Dendritic Cell Vaccine, Auranofin, Sirtuin Histone deacetylase inhibitor Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers NCT06648629NA1 site📍 Syracuse Syracuse University · Tests: Acceptance and Commitment Therapy (ACT), Brief Alcohol Intervention Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV NCT06554717Phase 22 sites📍 Aurora📍 Boston Massachusetts General Hospital · Tests: Tesamorelin, Placebo, Exercise Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance NCT06747507Phase 39 sites📍 Kisumu📍 Mombasa📍 Nairobi University of Nairobi · Tests: Dolutegravir Pill, Darunavir+Ritonavir HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia NCT06127290n/a4 sites📍 Cologne📍 Siena📍 Szczecin Euresist Network GEIE Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT) NCT05136703NA2 sites📍 Coral Gables📍 Miami Florida International University · Tests: Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD), Antiretroviral Therapy (ART) Adherence Counseling A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV NCT07392372Phase 16 sites📍 Chicago📍 Baltimore📍 St Louis BioNTech SE · Tests: BNT351, Placebo, BNT351, Placebo Analyses of Newly Diagnosed HIV Infection in Hong Kong NCT07725042n/a1 site📍 North Point Chinese University of Hong Kong IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study NCT07596888Phase 12 sites📍 Chapel Hill📍 Durham University of North Carolina, Chapel Hill · Tests: IAP086 0.3 mcg/kg, IAP086 1 mcg/kg, IAP086 3 mcg/kg, IAP086 6 mcg/kg, IAP086 10 mcg/kg Impacts of HIV Treatment Regimens on Archived Drug Resistance NCT07643948n/a1 site📍 Hong Kong Chinese University of Hong Kong Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States NCT07293559n/a11 sites📍 Los Angeles📍 Los Angeles📍 San Diego International Maternal Pediatric Adolescent AIDS Clinical T… · Tests: No intervention provided in this study Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV NCT05215704n/a1 site📍 Rotterdam Erasmus Medical Center Cannabis Use, Cognition, and the Endocannabinoid System in HIV NCT04883255EARLY Phase 11 site📍 San Diego University of California, San Diego · Tests: 10 mg Δ9-tetrahydrocannabinol (THC), 600 mg cannabidiol (CBD), Placebo A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1 NCT07275606Phase 1, Phase 21 site📍 Parow Valley ViiV Healthcare · Tests: Oral CAB, IM CAB LA
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy